Stockreport

Assessing Sarepta Therapeutics (SRPT) Valuation After SRP-1005 Huntington's Disease Trial Application [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF therapy targeting Huntington's Disease, highlighting progress in the company's next-generation siRNA platform. See our latest analysis for Sarepta Therapeutics. The [Read more]